Mativ Holdings, Inc. (NYSE:MATV - Get Free Report) Director Kimberly E. Ritrievi acquired 10,000 shares of the stock in a transaction on Thursday, May 29th. The stock was bought at an average price of $5.88 per share, with a total value of $58,800.00. Following the transaction, the director now directly owns 30,640 shares of the company's stock, valued at approximately $180,163.20. The trade was a 48.45% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Mativ Trading Up 5.0%
Shares of MATV traded up $0.31 during mid-day trading on Tuesday, hitting $6.48. 83,116 shares of the company's stock traded hands, compared to its average volume of 599,992. Mativ Holdings, Inc. has a 1 year low of $4.34 and a 1 year high of $19.96. The company has a quick ratio of 1.29, a current ratio of 2.40 and a debt-to-equity ratio of 1.28. The business's 50-day moving average price is $5.43 and its 200-day moving average price is $8.20. The firm has a market capitalization of $353.28 million, a P/E ratio of -7.20, a PEG ratio of 1.08 and a beta of 0.61.
Mativ (NYSE:MATV - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.03). The company had revenue of $484.80 million during the quarter, compared to the consensus estimate of $470.30 million. Mativ had a positive return on equity of 3.86% and a negative net margin of 2.46%. As a group, sell-side analysts forecast that Mativ Holdings, Inc. will post 1.15 EPS for the current fiscal year.
Mativ Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, June 27th. Investors of record on Friday, May 23rd will be issued a $0.10 dividend. The ex-dividend date is Friday, May 23rd. This represents a $0.40 dividend on an annualized basis and a yield of 6.17%. Mativ's dividend payout ratio is currently -4.88%.
Institutional Investors Weigh In On Mativ
A number of institutional investors and hedge funds have recently bought and sold shares of MATV. Federated Hermes Inc. purchased a new stake in shares of Mativ in the fourth quarter worth about $33,000. GAMMA Investing LLC increased its position in Mativ by 119.7% during the first quarter. GAMMA Investing LLC now owns 4,462 shares of the company's stock valued at $28,000 after acquiring an additional 2,431 shares during the last quarter. CWM LLC lifted its stake in shares of Mativ by 707.7% during the 1st quarter. CWM LLC now owns 4,701 shares of the company's stock worth $29,000 after acquiring an additional 4,119 shares during the last quarter. KBC Group NV grew its stake in Mativ by 93.2% in the fourth quarter. KBC Group NV now owns 4,787 shares of the company's stock worth $52,000 after purchasing an additional 2,309 shares in the last quarter. Finally, US Bancorp DE increased its stake in shares of Mativ by 204.2% during the first quarter. US Bancorp DE now owns 5,677 shares of the company's stock valued at $35,000 after buying an additional 3,811 shares during the period. 94.95% of the stock is owned by institutional investors.
Analyst Ratings Changes
Separately, Stifel Nicolaus upgraded shares of Mativ from a "hold" rating to a "buy" rating and dropped their target price for the stock from $15.50 to $10.00 in a report on Monday, March 24th.
Check Out Our Latest Stock Analysis on MATV
About Mativ
(
Get Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
See Also
Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.